Patents Assigned to CardioGenics Inc.
  • Patent number: 9039995
    Abstract: A testing cartridge for metering of a sample to be tested. The testing cartridge includes a casing defining a casing opening and a sliding member defining a sliding member opening. The casing opening or the sliding member opening can define a specified volume, wherein the casing opening and the sliding member opening collectively define a sample application region dimensioned to accommodate receiving an amount of sample exceeding the specified volume. The sliding member is movable transversely to the casing opening by having the sliding member and the casing traverse across each other's respective openings to remove excess sample from the received amount of sample and retain the specified volume from the received amount of sample.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: May 26, 2015
    Assignee: Cardiogenics Inc.
    Inventors: Stephen Daniel Thorogood, Paul Saunders
  • Patent number: 7964415
    Abstract: Water soluble, polyethylenimine polymers, conjugated to one or more active moiety are taught. Also taught are methods of making same, kits comprising same, and use of same in immunoassay systems.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: June 21, 2011
    Assignee: CardioGenics Inc.
    Inventors: Pavel Zhelev, Amer Alagic, Yahia A. Gawad
  • Publication number: 20100003701
    Abstract: A process for reversible chemical modification of the luciferase, a process for the covalent conjugation of a reversibly modified luciferase to a chemical moiety (a protein or a binding partner such as biotin or an antibody), a process for reactivation of the reversibly-modified and inactivated luciferase, a process for making the said luciferase conjugates and a bioluminescent assay method that uses covalently conjugated firefly luciferase are taught. The present invention also relates to a composition comprising a reversibly modified luciferase, as well as a composition comprising a reversibly modified luciferase covalently conjugated to a chemical moiety.
    Type: Application
    Filed: August 3, 2009
    Publication date: January 7, 2010
    Applicant: CardioGenics Inc.
    Inventors: Amer Alagic, Pavel Zhelev, Yahia A. Gawad
  • Publication number: 20070254285
    Abstract: Water soluble, polyethylenimine polymers, conjugated to one or more active moiety are taught. Also taught are methods of making same, kits comprising same, and use of same in immunoassay systems.
    Type: Application
    Filed: April 26, 2006
    Publication date: November 1, 2007
    Applicant: CardioGenics Inc.
    Inventors: Pavel Zhelev, Amer Alagic, Yahia Gawad
  • Publication number: 20070254311
    Abstract: A process for reversible chemical modification of the luciferase, a process for the covalent conjugation of a reversibly modified luciferase to a chemical moiety (a protein or a binding partner such as biotin or an antibody), a process for reactivation of the reversibly-modified and inactivated luciferase, a process for making the said luciferase conjugates and a bioluminescent assay method that uses covalently conjugated firefly luciferase are taught. The present invention also relates to a composition comprising a reversibly modified luciferase, as well as a composition comprising a reversibly modified luciferase covalently conjugated to a chemical moiety.
    Type: Application
    Filed: April 26, 2006
    Publication date: November 1, 2007
    Applicant: CardioGenics Inc.
    Inventors: Amer Alagic, Pavel Zhelev, Yahia Gawad